MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Express News | Mediwound Ltd Files for Resale of up to 1.45 Mln Ordinary Shares by Selling Shareholders - SEC Filing
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Announces Target Price $30
Maxim Group analyst Michael Okunewitch maintains $MediWound(MDWD.US)$ with a buy rating, and sets the target price at $30.According to TipRanks data, the analyst has a success rate of 31.2% and a
Mediwound Poised for Growth: Buy Rating Backed by NexoBrid Expansion and EscharEx Market Potential
MediWound Ltd.'s (NASDAQ:MDWD) Top Owners Are Retail Investors With 38% Stake, While 28% Is Held by Institutions
MediWound Receives Pediatric Indication for Burn Treatment NexoBrid